nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0559	0.207	CbGbCtD
Celecoxib—PTGS2—Etoposide—peripheral nervous system neoplasm	0.055	0.204	CbGbCtD
Celecoxib—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0444	0.165	CbGbCtD
Celecoxib—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0278	0.103	CbGbCtD
Celecoxib—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0258	0.0957	CbGbCtD
Celecoxib—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.019	0.0705	CbGbCtD
Celecoxib—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0119	0.044	CbGbCtD
Celecoxib—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0117	0.0432	CbGbCtD
Celecoxib—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0109	0.0403	CbGbCtD
Celecoxib—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00741	0.0275	CbGbCtD
Celecoxib—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000331	CcSEcCtD
Celecoxib—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000163	0.000331	CcSEcCtD
Celecoxib—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000329	CcSEcCtD
Celecoxib—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000328	CcSEcCtD
Celecoxib—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000327	CcSEcCtD
Celecoxib—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000327	CcSEcCtD
Celecoxib—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000161	0.000326	CcSEcCtD
Celecoxib—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000326	CcSEcCtD
Celecoxib—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000325	CcSEcCtD
Celecoxib—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00016	0.000324	CcSEcCtD
Celecoxib—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000323	CcSEcCtD
Celecoxib—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00016	0.000323	CcSEcCtD
Celecoxib—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000323	CcSEcCtD
Celecoxib—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000159	0.000322	CcSEcCtD
Celecoxib—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000321	CcSEcCtD
Celecoxib—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000319	CcSEcCtD
Celecoxib—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000319	CcSEcCtD
Celecoxib—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000158	0.000319	CcSEcCtD
Celecoxib—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000319	CcSEcCtD
Celecoxib—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000319	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000317	CcSEcCtD
Celecoxib—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000156	0.000317	CcSEcCtD
Celecoxib—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000156	0.000316	CcSEcCtD
Celecoxib—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000315	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000155	0.000314	CcSEcCtD
Celecoxib—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000155	0.000314	CcSEcCtD
Celecoxib—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000155	0.000313	CcSEcCtD
Celecoxib—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000313	CcSEcCtD
Celecoxib—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000311	CcSEcCtD
Celecoxib—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000311	CcSEcCtD
Celecoxib—Constipation—Etoposide—peripheral nervous system neoplasm	0.000154	0.000311	CcSEcCtD
Celecoxib—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00031	CcSEcCtD
Celecoxib—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000153	0.00031	CcSEcCtD
Celecoxib—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00031	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000308	CcSEcCtD
Celecoxib—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000308	CcSEcCtD
Celecoxib—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000152	0.000307	CcSEcCtD
Celecoxib—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000306	CcSEcCtD
Celecoxib—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000305	CcSEcCtD
Celecoxib—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000303	CcSEcCtD
Celecoxib—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000302	CcSEcCtD
Celecoxib—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000302	CcSEcCtD
Celecoxib—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000301	CcSEcCtD
Celecoxib—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000148	0.0003	CcSEcCtD
Celecoxib—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000148	0.0003	CcSEcCtD
Celecoxib—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000299	CcSEcCtD
Celecoxib—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000298	CcSEcCtD
Celecoxib—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000298	CcSEcCtD
Celecoxib—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000297	CcSEcCtD
Celecoxib—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000147	0.000297	CcSEcCtD
Celecoxib—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000147	0.000297	CcSEcCtD
Celecoxib—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000296	CcSEcCtD
Celecoxib—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000296	CcSEcCtD
Celecoxib—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000296	CcSEcCtD
Celecoxib—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000294	CcSEcCtD
Celecoxib—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000293	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000293	CcSEcCtD
Celecoxib—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000144	0.000292	CcSEcCtD
Celecoxib—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000292	CcSEcCtD
Celecoxib—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00029	CcSEcCtD
Celecoxib—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000143	0.000289	CcSEcCtD
Celecoxib—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000288	CcSEcCtD
Celecoxib—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000288	CcSEcCtD
Celecoxib—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000288	CcSEcCtD
Celecoxib—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000287	CcSEcCtD
Celecoxib—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000285	CcSEcCtD
Celecoxib—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000141	0.000285	CcSEcCtD
Celecoxib—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000285	CcSEcCtD
Celecoxib—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000285	CcSEcCtD
Celecoxib—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000283	CcSEcCtD
Celecoxib—Rash—Vincristine—peripheral nervous system neoplasm	0.00014	0.000283	CcSEcCtD
Celecoxib—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00014	0.000283	CcSEcCtD
Celecoxib—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000282	CcSEcCtD
Celecoxib—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000282	CcSEcCtD
Celecoxib—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000282	CcSEcCtD
Celecoxib—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000281	CcSEcCtD
Celecoxib—Headache—Vincristine—peripheral nervous system neoplasm	0.000139	0.000281	CcSEcCtD
Celecoxib—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00028	CcSEcCtD
Celecoxib—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000279	CcSEcCtD
Celecoxib—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000277	CcSEcCtD
Celecoxib—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000277	CcSEcCtD
Celecoxib—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000276	CcSEcCtD
Celecoxib—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000271	CcSEcCtD
Celecoxib—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000271	CcSEcCtD
Celecoxib—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000268	CcSEcCtD
Celecoxib—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000132	0.000268	CcSEcCtD
Celecoxib—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000267	CcSEcCtD
Celecoxib—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000267	CcSEcCtD
Celecoxib—Nausea—Vincristine—peripheral nervous system neoplasm	0.000132	0.000267	CcSEcCtD
Celecoxib—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000266	CcSEcCtD
Celecoxib—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000266	CcSEcCtD
Celecoxib—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000266	CcSEcCtD
Celecoxib—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000265	CcSEcCtD
Celecoxib—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000265	CcSEcCtD
Celecoxib—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000264	CcSEcCtD
Celecoxib—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000263	CcSEcCtD
Celecoxib—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000262	CcSEcCtD
Celecoxib—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000261	CcSEcCtD
Celecoxib—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000129	0.000261	CcSEcCtD
Celecoxib—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000261	CcSEcCtD
Celecoxib—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00026	CcSEcCtD
Celecoxib—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00026	CcSEcCtD
Celecoxib—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000259	CcSEcCtD
Celecoxib—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000258	CcSEcCtD
Celecoxib—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000127	0.000257	CcSEcCtD
Celecoxib—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000256	CcSEcCtD
Celecoxib—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000253	CcSEcCtD
Celecoxib—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000252	CcSEcCtD
Celecoxib—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000251	CcSEcCtD
Celecoxib—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000251	CcSEcCtD
Celecoxib—Rash—Cisplatin—peripheral nervous system neoplasm	0.000124	0.00025	CcSEcCtD
Celecoxib—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000124	0.00025	CcSEcCtD
Celecoxib—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000123	0.000249	CcSEcCtD
Celecoxib—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000248	CcSEcCtD
Celecoxib—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000247	CcSEcCtD
Celecoxib—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000246	CcSEcCtD
Celecoxib—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000246	CcSEcCtD
Celecoxib—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000246	CcSEcCtD
Celecoxib—Tension—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000245	CcSEcCtD
Celecoxib—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000244	CcSEcCtD
Celecoxib—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000242	CcSEcCtD
Celecoxib—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000241	CcSEcCtD
Celecoxib—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000241	CcSEcCtD
Celecoxib—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000119	0.00024	CcSEcCtD
Celecoxib—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000119	0.00024	CcSEcCtD
Celecoxib—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00024	CcSEcCtD
Celecoxib—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000239	CcSEcCtD
Celecoxib—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000237	CcSEcCtD
Celecoxib—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000236	CcSEcCtD
Celecoxib—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000235	CcSEcCtD
Celecoxib—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000234	CcSEcCtD
Celecoxib—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000232	CcSEcCtD
Celecoxib—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000114	0.000231	CcSEcCtD
Celecoxib—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000231	CcSEcCtD
Celecoxib—Rash—Etoposide—peripheral nervous system neoplasm	0.000113	0.000229	CcSEcCtD
Celecoxib—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000113	0.000229	CcSEcCtD
Celecoxib—Headache—Etoposide—peripheral nervous system neoplasm	0.000113	0.000228	CcSEcCtD
Celecoxib—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000228	CcSEcCtD
Celecoxib—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000227	CcSEcCtD
Celecoxib—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000226	CcSEcCtD
Celecoxib—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000224	CcSEcCtD
Celecoxib—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000224	CcSEcCtD
Celecoxib—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000224	CcSEcCtD
Celecoxib—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000223	CcSEcCtD
Celecoxib—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000223	CcSEcCtD
Celecoxib—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000222	CcSEcCtD
Celecoxib—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000221	CcSEcCtD
Celecoxib—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000219	CcSEcCtD
Celecoxib—Cough—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000218	CcSEcCtD
Celecoxib—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000218	CcSEcCtD
Celecoxib—Nausea—Etoposide—peripheral nervous system neoplasm	0.000107	0.000216	CcSEcCtD
Celecoxib—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000216	CcSEcCtD
Celecoxib—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000213	CcSEcCtD
Celecoxib—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000213	CcSEcCtD
Celecoxib—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000213	CcSEcCtD
Celecoxib—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000213	CcSEcCtD
Celecoxib—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000212	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000211	CcSEcCtD
Celecoxib—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000208	CcSEcCtD
Celecoxib—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000208	CcSEcCtD
Celecoxib—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000207	CcSEcCtD
Celecoxib—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000207	CcSEcCtD
Celecoxib—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000205	CcSEcCtD
Celecoxib—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000204	CcSEcCtD
Celecoxib—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000204	CcSEcCtD
Celecoxib—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000204	CcSEcCtD
Celecoxib—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000203	CcSEcCtD
Celecoxib—Infection—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000202	CcSEcCtD
Celecoxib—Cough—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000202	CcSEcCtD
Celecoxib—Shock—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.0002	CcSEcCtD
Celecoxib—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.87e-05	0.0002	CcSEcCtD
Celecoxib—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000199	CcSEcCtD
Celecoxib—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000199	CcSEcCtD
Celecoxib—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.83e-05	0.000199	CcSEcCtD
Celecoxib—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.78e-05	0.000198	CcSEcCtD
Celecoxib—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.73e-05	0.000197	CcSEcCtD
Celecoxib—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000197	CcSEcCtD
Celecoxib—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000197	CcSEcCtD
Celecoxib—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000197	CcSEcCtD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—peripheral nervous system neoplasm	9.7e-05	0.000411	CbGpPWpGaD
Celecoxib—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000196	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000195	CcSEcCtD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	9.64e-05	0.000408	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—NRAS—peripheral nervous system neoplasm	9.62e-05	0.000407	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.6e-05	0.000407	CbGpPWpGaD
Celecoxib—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000194	CcSEcCtD
Celecoxib—MAPK14—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	9.53e-05	0.000404	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—GNAS—peripheral nervous system neoplasm	9.53e-05	0.000403	CbGpPWpGaD
Celecoxib—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000192	CcSEcCtD
Celecoxib—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.44e-05	0.0004	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.42e-05	0.000399	CbGpPWpGaD
Celecoxib—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.39e-05	0.00019	CcSEcCtD
Celecoxib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	9.38e-05	0.000397	CbGpPWpGaD
Celecoxib—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000189	CcSEcCtD
Celecoxib—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.32e-05	0.000189	CcSEcCtD
Celecoxib—CA2—Metabolism—TH—peripheral nervous system neoplasm	9.31e-05	0.000394	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—AKT1—peripheral nervous system neoplasm	9.26e-05	0.000392	CbGpPWpGaD
Celecoxib—Infection—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000187	CcSEcCtD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.24e-05	0.000391	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD34—peripheral nervous system neoplasm	9.24e-05	0.000391	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	9.21e-05	0.00039	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000186	CcSEcCtD
Celecoxib—Shock—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.000185	CcSEcCtD
Celecoxib—PDPK1—Immune System—HGF—peripheral nervous system neoplasm	9.16e-05	0.000388	CbGpPWpGaD
Celecoxib—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000185	CcSEcCtD
Celecoxib—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000185	CcSEcCtD
Celecoxib—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000184	CcSEcCtD
Celecoxib—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	9.1e-05	0.000385	CbGpPWpGaD
Celecoxib—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000184	CcSEcCtD
Celecoxib—MAPK14—Hemostasis—HGF—peripheral nervous system neoplasm	9.08e-05	0.000384	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	9.07e-05	0.000384	CbGpPWpGaD
Celecoxib—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.05e-05	0.000183	CcSEcCtD
Celecoxib—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000183	CcSEcCtD
Celecoxib—PDPK1—Neuronal System—HRAS—peripheral nervous system neoplasm	9.02e-05	0.000382	CbGpPWpGaD
Celecoxib—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000182	CcSEcCtD
Celecoxib—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000182	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—MYC—peripheral nervous system neoplasm	8.96e-05	0.000379	CbGpPWpGaD
Celecoxib—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000181	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—peripheral nervous system neoplasm	8.92e-05	0.000378	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	8.91e-05	0.000377	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PPP3R1—peripheral nervous system neoplasm	8.89e-05	0.000377	CbGpPWpGaD
Celecoxib—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.00018	CcSEcCtD
Celecoxib—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.86e-05	0.000179	CcSEcCtD
Celecoxib—PDPK1—Signaling by NGF—HRAS—peripheral nervous system neoplasm	8.85e-05	0.000375	CbGpPWpGaD
Celecoxib—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000177	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	8.71e-05	0.000369	CbGpPWpGaD
Celecoxib—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000176	CcSEcCtD
Celecoxib—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.69e-05	0.000368	CbGpPWpGaD
Celecoxib—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000176	CcSEcCtD
Celecoxib—Constipation—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000174	CcSEcCtD
Celecoxib—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.59e-05	0.000364	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.52e-05	0.000361	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	8.49e-05	0.00036	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000172	CcSEcCtD
Celecoxib—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.00017	CcSEcCtD
Celecoxib—MAPK14—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	8.41e-05	0.000356	CbGpPWpGaD
Celecoxib—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000169	CcSEcCtD
Celecoxib—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	8.34e-05	0.000353	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.31e-05	0.000352	CbGpPWpGaD
Celecoxib—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000168	CcSEcCtD
Celecoxib—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000168	CcSEcCtD
Celecoxib—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000168	CcSEcCtD
Celecoxib—MAPK14—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	8.26e-05	0.00035	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.23e-05	0.000167	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.22e-05	0.000348	CbGpPWpGaD
Celecoxib—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.2e-05	0.000166	CcSEcCtD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	8.17e-05	0.000346	CbGpPWpGaD
Celecoxib—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000164	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.09e-05	0.000342	CbGpPWpGaD
Celecoxib—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000163	CcSEcCtD
Celecoxib—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000163	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	8.03e-05	0.00034	CbGpPWpGaD
Celecoxib—Urticaria—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000162	CcSEcCtD
Celecoxib—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000161	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	7.96e-05	0.000337	CbGpPWpGaD
Celecoxib—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000161	CcSEcCtD
Celecoxib—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.96e-05	0.000161	CcSEcCtD
Celecoxib—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.96e-05	0.000337	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	7.92e-05	0.000336	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.88e-05	0.000334	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NCAM1—peripheral nervous system neoplasm	7.86e-05	0.000333	CbGpPWpGaD
Celecoxib—CA9—Metabolism—TH—peripheral nervous system neoplasm	7.84e-05	0.000332	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	7.83e-05	0.000331	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—AKT1—peripheral nervous system neoplasm	7.81e-05	0.000331	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.78e-05	0.000329	CbGpPWpGaD
Celecoxib—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000155	CcSEcCtD
Celecoxib—PDPK1—Hemostasis—NRAS—peripheral nervous system neoplasm	7.66e-05	0.000324	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000154	CcSEcCtD
Celecoxib—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	7.6e-05	0.000322	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	7.59e-05	0.000322	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	7.56e-05	0.00032	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—AKT1—peripheral nervous system neoplasm	7.54e-05	0.000319	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GNS—peripheral nervous system neoplasm	7.5e-05	0.000318	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—CASP3—peripheral nervous system neoplasm	7.5e-05	0.000318	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.45e-05	0.000316	CbGpPWpGaD
Celecoxib—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.00015	CcSEcCtD
Celecoxib—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.00015	CcSEcCtD
Celecoxib—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000149	CcSEcCtD
Celecoxib—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000149	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	7.36e-05	0.000312	CbGpPWpGaD
Celecoxib—MAPK14—Insulin Signaling—HRAS—peripheral nervous system neoplasm	7.32e-05	0.00031	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.31e-05	0.00031	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MET—peripheral nervous system neoplasm	7.3e-05	0.000309	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.29e-05	0.000309	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	7.24e-05	0.000307	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—AKT1—peripheral nervous system neoplasm	7.23e-05	0.000306	CbGpPWpGaD
Celecoxib—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000146	CcSEcCtD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.22e-05	0.000306	CbGpPWpGaD
Celecoxib—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.12e-05	0.000144	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.11e-05	0.000301	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.03e-05	0.000298	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	7.03e-05	0.000298	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—NRAS—peripheral nervous system neoplasm	6.9e-05	0.000292	CbGpPWpGaD
Celecoxib—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000139	CcSEcCtD
Celecoxib—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000139	CcSEcCtD
Celecoxib—MAPK14—Cellular Senescence—TP53—peripheral nervous system neoplasm	6.78e-05	0.000287	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.77e-05	0.000287	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PTPN11—peripheral nervous system neoplasm	6.75e-05	0.000286	CbGpPWpGaD
Celecoxib—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.000135	CcSEcCtD
Celecoxib—PDPK1—Immune System—PTPN11—peripheral nervous system neoplasm	6.68e-05	0.000283	CbGpPWpGaD
Celecoxib—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000135	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.64e-05	0.000281	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	6.62e-05	0.00028	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.62e-05	0.00028	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.62e-05	0.00028	CbGpPWpGaD
Celecoxib—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.59e-05	0.000133	CcSEcCtD
Celecoxib—MAPK14—Insulin Signaling—AKT1—peripheral nervous system neoplasm	6.46e-05	0.000274	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	6.4e-05	0.000271	CbGpPWpGaD
Celecoxib—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.00013	CcSEcCtD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	6.4e-05	0.000271	CbGpPWpGaD
Celecoxib—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.37e-05	0.000129	CcSEcCtD
Celecoxib—Rash—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000128	CcSEcCtD
Celecoxib—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000128	CcSEcCtD
Celecoxib—Headache—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000128	CcSEcCtD
Celecoxib—MAPK14—Signaling by NGF—NRAS—peripheral nervous system neoplasm	6.28e-05	0.000266	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.28e-05	0.000266	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	6.28e-05	0.000266	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	6.24e-05	0.000264	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.23e-05	0.000264	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.22e-05	0.000263	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	6.21e-05	0.000263	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTPN11—peripheral nervous system neoplasm	6.17e-05	0.000261	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNB1—peripheral nervous system neoplasm	6.16e-05	0.000261	CbGpPWpGaD
Celecoxib—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000125	CcSEcCtD
Celecoxib—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	6.08e-05	0.000257	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	6.02e-05	0.000255	CbGpPWpGaD
Celecoxib—Nausea—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000121	CcSEcCtD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	5.98e-05	0.000253	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTPN11—peripheral nervous system neoplasm	5.96e-05	0.000252	CbGpPWpGaD
Celecoxib—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.00012	CcSEcCtD
Celecoxib—Rash—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000119	CcSEcCtD
Celecoxib—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000119	CcSEcCtD
Celecoxib—PDPK1—Hemostasis—TP53—peripheral nervous system neoplasm	5.86e-05	0.000248	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.84e-05	0.000247	CbGpPWpGaD
Celecoxib—Headache—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000118	CcSEcCtD
Celecoxib—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.8e-05	0.000246	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	5.8e-05	0.000245	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.75e-05	0.000244	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.75e-05	0.000243	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	5.7e-05	0.000241	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	5.63e-05	0.000238	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.62e-05	0.000238	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.61e-05	0.000237	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—HRAS—peripheral nervous system neoplasm	5.6e-05	0.000237	CbGpPWpGaD
Celecoxib—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000112	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—ERBB2—peripheral nervous system neoplasm	5.33e-05	0.000226	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.3e-05	0.000224	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ERBB2—peripheral nervous system neoplasm	5.28e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	5.28e-05	0.000224	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	5.25e-05	0.000222	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.17e-05	0.000219	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—peripheral nervous system neoplasm	5.13e-05	0.000217	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNS—peripheral nervous system neoplasm	5.08e-05	0.000215	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—HRAS—peripheral nervous system neoplasm	5.05e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of mRNA—AKT1—peripheral nervous system neoplasm	5.03e-05	0.000213	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.99e-05	0.000211	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—AKT1—peripheral nervous system neoplasm	4.95e-05	0.00021	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	4.92e-05	0.000209	CbGpPWpGaD
Celecoxib—PDPK1—Disease—ERBB2—peripheral nervous system neoplasm	4.88e-05	0.000206	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NME1—peripheral nervous system neoplasm	4.87e-05	0.000206	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	4.85e-05	0.000205	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.78e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HGF—peripheral nervous system neoplasm	4.76e-05	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ERBB2—peripheral nervous system neoplasm	4.71e-05	0.0002	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	4.69e-05	0.000199	CbGpPWpGaD
Celecoxib—ALB—Metabolism—COX2—peripheral nervous system neoplasm	4.69e-05	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—HRAS—peripheral nervous system neoplasm	4.6e-05	0.000195	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	4.55e-05	0.000193	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	4.54e-05	0.000192	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—AKT1—peripheral nervous system neoplasm	4.46e-05	0.000189	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.4e-05	0.000186	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.32e-05	0.000183	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.32e-05	0.000183	CbGpPWpGaD
Celecoxib—MAPK14—Metabolism of RNA—AKT1—peripheral nervous system neoplasm	4.3e-05	0.000182	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	4.28e-05	0.000181	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.26e-05	0.000181	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.24e-05	0.00018	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	4.2e-05	0.000178	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.18e-05	0.000177	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	4.16e-05	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—AKT1—peripheral nervous system neoplasm	4.06e-05	0.000172	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NRAS—peripheral nervous system neoplasm	4.06e-05	0.000172	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.02e-05	0.00017	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NRAS—peripheral nervous system neoplasm	4.02e-05	0.00017	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	3.99e-05	0.000169	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NRAS—peripheral nervous system neoplasm	3.98e-05	0.000169	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	3.87e-05	0.000164	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	3.84e-05	0.000163	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	3.81e-05	0.000161	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.79e-05	0.000161	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NRAS—peripheral nervous system neoplasm	3.71e-05	0.000157	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.69e-05	0.000156	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	3.66e-05	0.000155	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NRAS—peripheral nervous system neoplasm	3.58e-05	0.000152	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.58e-05	0.000152	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.52e-05	0.000149	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	3.48e-05	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTPN11—peripheral nervous system neoplasm	3.47e-05	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MYC—peripheral nervous system neoplasm	3.45e-05	0.000146	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.42e-05	0.000145	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.41e-05	0.000145	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	3.33e-05	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.23e-05	0.000137	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.22e-05	0.000136	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	3.22e-05	0.000136	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	3.18e-05	0.000135	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.13e-05	0.000132	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—peripheral nervous system neoplasm	3.1e-05	0.000131	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	3.1e-05	0.000131	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.1e-05	0.000131	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	3.08e-05	0.00013	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.07e-05	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—peripheral nervous system neoplasm	3.05e-05	0.000129	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	3.02e-05	0.000128	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.97e-05	0.000126	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—peripheral nervous system neoplasm	2.94e-05	0.000124	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	2.94e-05	0.000124	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—peripheral nervous system neoplasm	2.91e-05	0.000123	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	2.89e-05	0.000123	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.84e-05	0.00012	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB2—peripheral nervous system neoplasm	2.74e-05	0.000116	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.74e-05	0.000116	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—peripheral nervous system neoplasm	2.71e-05	0.000115	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—peripheral nervous system neoplasm	2.68e-05	0.000114	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.63e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.62e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.62e-05	0.000111	CbGpPWpGaD
Celecoxib—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	2.6e-05	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.6e-05	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—peripheral nervous system neoplasm	2.6e-05	0.00011	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.58e-05	0.000109	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—peripheral nervous system neoplasm	2.57e-05	0.000109	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.54e-05	0.000108	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.53e-05	0.000107	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	2.52e-05	0.000107	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.48e-05	0.000105	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	2.47e-05	0.000105	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TH—peripheral nervous system neoplasm	2.45e-05	0.000104	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.42e-05	0.000103	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.42e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—peripheral nervous system neoplasm	2.4e-05	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.32e-05	9.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	9.51e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.15e-05	9.1e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	2.14e-05	9.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.13e-05	9.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NRAS—peripheral nervous system neoplasm	2.09e-05	8.84e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2.06e-05	8.71e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	2.05e-05	8.68e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.05e-05	8.68e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	2.05e-05	8.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.03e-05	8.6e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.02e-05	8.55e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2e-05	8.48e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2e-05	8.46e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.99e-05	8.41e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	1.96e-05	8.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—peripheral nervous system neoplasm	1.93e-05	8.19e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.9e-05	8.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	7.51e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-05	7.32e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.68e-05	7.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.66e-05	7.04e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.65e-05	6.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.63e-05	6.92e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	1.62e-05	6.85e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.62e-05	6.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.61e-05	6.82e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.6e-05	6.79e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.57e-05	6.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—peripheral nervous system neoplasm	1.53e-05	6.47e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.51e-05	6.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-05	5.95e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.35e-05	5.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—peripheral nervous system neoplasm	1.35e-05	5.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—peripheral nervous system neoplasm	1.34e-05	5.68e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	5.67e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.33e-05	5.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	5.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.26e-05	5.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	1.23e-05	5.21e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—peripheral nervous system neoplasm	1.15e-05	4.86e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	4.56e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	4.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	4.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.87e-06	4.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	9.01e-06	3.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.72e-06	3.69e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	7.95e-06	3.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	6.66e-06	2.82e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	5.39e-06	2.28e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.45e-06	1.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	4.41e-06	1.87e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.91e-06	1.23e-05	CbGpPWpGaD
